ALERT!

This site is not optimized for Internet Explorer 8 (or older).

Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.

Current Results of Left Ventricular Assist Device Therapy in France: The ASSIST-ICD Registry

Wednesday, July 15, 2020

Submitted by

Emily Robinson

Source

Source Name: European Journal of Cardio-Thoracic Surgery

Source URL: https://doi.org/10.1093/ejcts/ezaa055

Author(s)

Amedeo Anselmi, Vincent Galand, André Vincentelli, Stéphane Boule, Camille Dambrin, Clément Delmas, Laurent Barandon, Mathieu Pernot, Michel Kindo, Hoang Minh Tam, Philippe Gaudard, Philippe Rouviere, Thomas Senage, Magali Michel, Aude Boignard, Olivier Chavanon, Constance Verdonk, Marylou Para, Vlad Gariboldi, Edeline Pelce, Matteo Pozzi, Jean-François Obadia, Frederic Anselme, Pierre-Yves Litzler, Gerard Babatasi, Annette Belin, Fabien Garnier, Marie Bielefeld, Julien Guihaire, Martin Kloeckner, Costin Radu, Nicolas Lellouche, Thierry Bourguignon, Thibaud Genet, Nicolas D’Ostrevy, Benjamin Duband, Jerome Jouan, Marie Cécile Bories, Fabrice Vanhuyse, Hugues Blangy, Fabrice Colas, Jean-Philippe Verhoye, Raphael Martins, Erwan Flecher On behalf of the Determination of Risk Factors of Ventricular Arrhythmias After Implantation of Continuous Flow Left Ventricular Assist Device (ASSIST-ICD) Investigators

This original article retrospectively analyzed the outcome of 671 patients undergoing LVAD implantation within the French multicenter ASSIST-ICD registry. While half of the patients were in cardiogenic shock and more than 20% of patients were on ECLS prior to implantation, the survival at five years is around 50%. This reflects the real world and all-comers nature of this registry and therefore provides a frank picture of LVAD outcomes in France between 2007 and 2017. Looking at their results, the authors recommend earlier referral of heart failure patients to lower the 50% rate of patients being in cardiogenic shock prior to implantation and thereby improving result of LVAD therapy in France.